Collegium Pharmaceutical Inc (COLL)
EBITDA Growth
-24.13%
Quarterly · Period ending:
COLL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-24.13%period ending
Latest reported-24.13%period ending
COLL Quarterly EBITDA YoY % (5.49% → -24.13%)
Year-over-year change
High-resolution chart · PNG
COLL ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -24.1275% | |
| 11.9278% | |
| 97.2583% | |
| 60.7335% | |
| 17.3984% | |
| -9.9771% | |
| -4.9471% | |
| -12.6662% | |
| 2.734% | |
| 112.0727% | |
| 81.5309% | |
| 48.1647% | |
| 58.3415% | |
| 337.8623% | |
| 430.6982% | |
| 86.3868% | |
| 46.5033% | |
| -74.9486% | |
| -152.689% | |
| -14.2631% | |
| 0.2325% | |
| 143.746% | |
| 1,593.5058% | |
| 1,919.1257% | |
| 5,538.2496% | |
| 381.8377% | |
| -93.0689% | |
| -109.1805% | |
| -102.4101% | |
| -132.7978% | |
| 258.2007% | |
| 266.9865% | |
| 221.9269% | |
| 174.578% | |
| 36.6895% | |
| 49.8223% | |
| 14.0524% | |
| -47.1307% | |
| -190.3991% | |
| -183.6133% | |
| -439.4127% | |
| -345.0043% | |
| -186.3456% | |
| -42.8549% | |
| -12.0762% | |
| 5.4924% |